Gartner, Inc. Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations
Gartner, Inc. (IT) reported Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations of $7.91 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-12.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations · last filed 2026-02-12
- Gartner, Inc. unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for the quarter ending 2011-12-31 was -$3.07M.
- Gartner, Inc. unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for the quarter ending 2011-09-30 was $1.60M.
- Gartner, Inc. unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2025 was $7.91M, a 25.18% decline from fiscal 2024.
- Gartner, Inc. unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2024 was $10.57M, a 32.33% decline from fiscal 2023.
- Gartner, Inc. unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2023 was $15.63M, a 49.30% decline from fiscal 2022.
- Gartner, Inc. unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2022 was $30.82M, a 851.14% increase from fiscal 2021.
| Period end | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 3 month | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 6 month | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 9 month | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 12 month | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $7.91M 10-K · filed 2026-02-12 | ||||
| 2024-12-31 | $10.57M 10-K · filed 2026-02-12 | ||||
| 2023-12-31 | $15.63M 10-K · filed 2026-02-12 | ||||
| 2022-12-31 | $30.82M 10-K · filed 2024-02-15 | ||||
| 2021-12-31 | $3.24M 10-K · filed 2023-02-16 | ||||
| 2020-12-31 | $8.19M 10-K · filed 2022-02-23 | ||||
| 2019-12-31 | $7.48M 10-K · filed 2021-02-24 | ||||
| 2018-12-31 | $6.29M 10-K · filed 2020-02-19 | ||||
| 2017-12-31 | $1.37M 10-K · filed 2019-02-22 | ||||
| 2016-12-31 | $1.01M 10-K · filed 2018-02-22 | ||||
| 2015-12-31 | $2.29M 10-K · filed 2017-02-22 | ||||
| 2014-12-31 | $1.03M 10-K · filed 2016-02-24 | ||||
| 2013-12-31 | $3.86M 10-K · filed 2015-02-27 | ||||
| 2012-12-31 | $296.00K 10-K · filed 2014-02-26 | -$296.00K 10-K · filed 2013-02-22 | |||
| 2011-12-31 | -$3.07M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-22 | -$1.47M derived: sum of 2 quarters · filed 2013-02-22 | -$269.00K 10-K · filed 2013-02-22 | $269.00K 10-K · filed 2012-02-23 | |
| 2011-09-30 | $1.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-01 | $2.80M 10-Q · filed 2011-11-01 | |||
| 2011-06-30 | $1.20M 10-Q · filed 2011-08-02 | ||||
| 2010-12-31 | $610.00K 10-K · filed 2012-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Evolent Health, Inc. (EVH) | United States | $0.397B | -1.21 |
| FRANKLIN COVEY CO (FC) | United States | $0.195B | 123.76 |